Defective Breast Mesh, Acellular Dermal Matrix, and Bioabsorbable Scaffold Injury Attorneys in South Dakota: The Complete Guide for Women and Families
We understand that for many women in South Dakota, the path to recovery after a mastectomy or a complex breast surgery is both a physical and emotional journey. You put your trust in the medical systems serving our region—whether you sought care at a major hub like Sioux Falls or traveled from more rural areas like Pierre, Aberdeen, or the Black Hills for specialized surgery. When that trust is broken by a defective medical device that was never properly cleared for use in breast tissue, the consequences can be devastating.
If you are currently facing complications like infection, chronic pain, reconstruction failure, or a diagnosis of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL), we want you to know that you are not alone. At Attorney911 (The Manginello Law Firm, PLLC), we focus on representating women who have been harmed by acellular dermal matrix (ADM), bioabsorbable scaffolds, and surgical mesh products that the FDA has now confirmed were never determined to be safe or effective for breast surgery.
Our team, led by Ralph Manginello—who has been licensed by the State Bar of Texas (Bar Card No. 24007597) for twenty-seven years and is admitted to practice in the United States District Court—brings a deep substantive command of federal medical device litigation. We are joined by associate attorney Lupe Peña, who provides full client consultations in fluent Spanish, ensuring that language is never a barrier to justice for the families we serve. We represent clients in high-profile, multi-defendant institutional liability cases, such as the current $10,000,000 Bermudez v. Pi Kappa Phi litigation, proving our capacity to take on the world’s largest manufacturers and organizations. If you have questions about what happened to your body, call us at 1-888-ATTY-911 (1-888-288-9911) for a confidential, no-cost consultation.
Understanding the Devices: What Was Implanted in Your Body?
Many patients in South Dakota are only now learning that the “reinforcement” or “internal bra” used during their procedure involved products not originally designed for the breast. These devices generally fall into three categories:
Acellular Dermal Matrix (ADM)
ADM is a biologic material derived from donated human or animal skin. In a process known as decellularization, cells are removed to leave behind a scaffold of collagen. Popular brands used in South Dakota surgical centers include AlloDerm (made by Allergan/AbbVie), Strattice, FlexHD (MTF Biologics), and AlloMax (C.R. Bard/BD). While surgeons often use these to support an implant or tissue expander, the FDA issued a safety communication on March 31, 2021, warning that FlexHD and AlloMax showed significantly higher rates of infection and reoperation.
Bioabsorbable and Resorbable Scaffolds
These are synthetic materials designed to slowly dissolve as your own tissue grows into the area. The most controversial of these products are made from poly-4-hydroxybutyrate (P4HB), such as GalaFLEX and Phasix. Manufactured by subsidiaries of Becton Dickinson (BD), these scaffolds are often marketed as an “internal bra” to prevent breast sagging or to support the lower pole of the breast. However, we have seen cases where these scaffolds fail to resorb on time, leading to palpable mesh edges, chronic inflammation, and the need for painful revision surgery in South Dakota.
Synthetic Surgical Mesh
Occasionally, permanent synthetic meshes made of polypropylene (similar to those used in hernia repair) are used off-label in the breast. Because these materials were never designed for the delicate environment of breast tissue, the risk of erosion and chronic pain is significantly elevated.
Whether your surgery took place at a major facility in Sioux Falls or a regional hospital in Rapid City, knowing exactly what was implanted is the first step toward a legal claim. We can help you navigate the process of obtaining your operative reports and device stickers to identify the specific brand at fault. Call Ralph Manginello and the team at 1-888-ATTY-911 to discuss your medical history.
The FDA Regulatory Failure and “Predicate Creep”
The fundamental issue we address in these lawsuits is how these devices reached the market without being tested in breast tissue. Most mesh and ADM products entered the market through the 510(k) clearance pathway (21 USC §360c). This is not the same as FDA approval. Under 21 CFR Part 807, a manufacturer only needs to show that their new device is “substantially equivalent” to a “predicate device” already on the market.
This has led to a phenomenon known as “predicate creep.” For example, the manufacturer of GalaFLEX cited a surgical suture as one of its predicate devices to gain clearance. A suture is not a mesh, and the mechanical stresses of the breast are far different from those of a simple wound closure.
On November 9, 2023, the FDA issued a critical letter to healthcare providers specifically naming Phasix Mesh and GalaFLEX Scaffold products. The agency stated verbatim: “The safety and effectiveness of surgical mesh in breast surgery, including in augmentation or reconstruction, has not been determined by the FDA.”
For a woman in South Dakota who was told her reconstruction was safe, this regulatory revelation is life-changing. It means the manufacturer may have promoted these products off-label while knowing they lacked the clinical data required to ensure patient safety. Our firm uses our extensive knowledge of 21 CFR Part 803 (Medical Device Reporting) and federal preemption doctrine, including Medtronic v. Lohr, 518 U.S. 470 (1996), to fight manufacturer claims that they are “protected” by FDA clearance.
The Spectrum of Injuries Facing South Dakota Patients
We are currently investigating a wide range of complications that have left women in South Dakota physically and emotionally scarred. These injuries include:
- Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL): This is a CD30-positive, ALK-negative T-cell lymphoma recognized by the World Health Organization as a distinct disease. It is strongly associated with textured surfaces, such as those found on the recalled Allergan BIOCELL implants often used alongside mesh.
- Breast Implant-Associated Squamous Cell Carcinoma (BIA-SCC): A rarer but aggressive cancer identified in the capsule surrounding the implant.
- Red Breast Syndrome (RBS): A non-infectious, sterile inflammation specific to ADM. Research indicates this may be caused by endotoxin contamination—bacterial fragments that survive sterilization—which triggers a chronic “redness” and inflammatory response in the breast.
- Skin-Flap Necrosis and Wound Dehiscence: The death of breast tissue overlying the implant, often leading to the exposure of the mesh and the total loss of the reconstruction.
- Capsular Contracture (Baker Grade III/IV): Severe hardening of the breast tissue that is painful and distorting, often exacerbated by the inflammatory response to a synthetic scaffold.
- Sepsis and Systemic Infection: Deep surgical site infections that can become life-threatening, requiring hospitalization and months of IV antibiotics.
If you have experienced any of these complications, or if you had to undergo an unplanned explant or “flat closure” because your reconstruction failed, you deserve to know if a defective device played a role. Lupe Peña and Ralph Manginello are available at 1-888-ATTY-911 to listen to your story. Hablamos español, and we are committed to providing the same high-level representation to every South Dakota family.
Local Realities: Litigation and Quality of Care in South Dakota
South Dakota is home to two major healthcare systems, Sanford Health and Avera Health, which provide the vast majority of oncology and reconstructive care in cities like Sioux Falls and Rapid City. While these institutions employ many talented surgeons, they are often the primary customers for device manufacturers like Becton Dickinson and Allergan.
Under the Learned Intermediary Doctrine, manufacturers often try to blame the surgeon for choosing the product. However, our firm looks deeper. We investigate whether the manufacturer’s sales representatives provided misleading training or if they marketed the device off-label to South Dakota surgeons without disclosing the true risks found in the MAUDE (Manufacturer and User Facility Device Experience) database.
The Statute of Limitations in South Dakota
In South Dakota, the statute of limitations for a product liability claim (SDCL § 15-2-12.2) is generally three years from the date the injury occurred or was discovered. Because complications from mesh and ADM often develop years after the initial surgery—with BIA-ALCL appearing on average 7 to 10 years post-implantation—the “Discovery Rule” is vital.
The FDA’s November 2023 safety communication may serve as the “discovery” point for many women in South Dakota who previously didn’t know their mesh was not FDA-approved for their surgery. However, these deadlines are strict. Waiting too long can bar you from ever seeking compensation. Contact Attorney911 at 1888-ATTY-911 immediately to ensure your rights are protected.
Whistleblower Evidence: The Case Against Becton Dickinson
Our litigation strategy is bolstered by the record of Dr. Hooman Noorchashm, a former Medical Director at Becton Dickinson (the maker of GalaFLEX and Phasix). Dr. Noorchashm was reportedly terminated in 2022 after raising serious alarms about the safety of surgical mesh in breast reconstruction.
His allegations include claims that breast cancer recurrences in GalaFLEX clinical trials were withheld from the FDA and that the company participated in dangerous off-label marketing. This kind of “insider knowledge” is crucial in proving that manufacturers prioritized corporate revenue—BD has reported billions in annual revenue—over the health of women in South Dakota.
Why Choose Attorney911?
When you are fighting a multi-billion-dollar manufacturer, you need a firm with the resources and the verified track record to succeed.
- Continuous Practice Since 1998: Ralph Manginello has twenty-seven years of experience and carries an Avvo Rating of 8.2 (Excellent) and a Martindale-Hubbell Preeminent rating.
- Proven High-Stakes Litigation: We are lead counsel in major cases like Bermudez v. Pi Kappa Phi, where we are seeking $10,000,000 in damages against thirteen defendants. We apply this same aggressive, multi-defendant structural approach to medical device suits.
- No Language Barrier: With Lupe Peña providing full consultations in Spanish, we ensure that the thousands of Spanish-speaking families in South Dakota have direct, attorney-led access to the legal system.
- No Fee Unless We Recover: We work on a contingency fee basis. You pay nothing upfront, and we only get paid if we secure a recovery for you.
Our firm is a member of the Pro Bono College of the State Bar of Texas, reflecting our commitment to service, and our high ratings on Birdeye (4.9/5.0 stars across hundreds of reviews) and the Better Business Bureau demonstrate the level of care we provide to our clients.
Frequently Asked Questions for South Dakota Patients
Is surgical mesh actually approved for breast surgery?
No. As the FDA stated in November 2023, no surgical mesh products have been cleared or approved for use in breast surgery. They are used “off-label” by surgeons, but manufacturers cannot legally promote them for this use.
What if I had my surgery years ago?
You may still have a case. Because many mesh-related injuries are latent (meaning they take time to develop), South Dakota law may allow you to file a claim within three years of when you discovered the link between your injury and the device.
Do I have to sue my surgeon?
Not necessarily. Most of these cases are Product Liability lawsuits filed against the manufacturer of the mesh, ADM, or scaffold. While we investigate all parties, including the hospital or surgical center, the focus is typically on the company that put a defective product on the market.
What kind of compensation can I recover?
We seek damages for your additional medical expenses, the cost of revision surgeries, lost wages (including those of a spouse or caregiver), permanent disfigurement, and pain and suffering.
How do I find out what brand was used in my surgery at Sanford or Avera?
You have a legal right to your medical records. We can assist you in requesting a “certified” copy of your operative report and “implant log” from the South Dakota facility where your surgery was performed.
Your Path Forward in South Dakota
We understand that speaking with a lawyer can feel overwhelming when you are already dealing with a medical crisis. Whether you are a breast cancer survivor who just found out your reconstruction is failing or a victim of a botched cosmetic augmentation, we are here to provide the support and the authoritative legal guidance you need.
Do not wait until the statute of limitations expires. Protecting your health is your first priority; protecting your legal rights is ours. Ralph Manginello and Lupe Peña are ready to take your call.
Call Attorney911 at 1-888-ATTY-911 (1-888-288-9911) today for a free, confidential consultation.
Note: Past results do not guarantee future outcomes. This content is for educational purposes and does not constitute legal advice. No attorney-client relationship is formed until a written representation agreement is signed.
Detailed Analysis of Defective ADM and Bioabsorbable Scaffolds
For women in South Dakota, the decision to undergo reconstruction often follows the trauma of a cancer diagnosis. When manufacturers market ADM products like AlloDerm or FlexHD to surgeons in the Sioux Falls region, they often frame it as a way to “speed up” the expansion process or provide a more “natural” lower-pole shape.
The Endotoxin Concern: Red Breast Syndrome
What these manufacturers often fail to mention is how they process the tissue. Biologic ADMs are washed in detergents and antibiotics, but they must also be sterilized. Some products are “terminally sterilized” using gamma irradiation, while others are only “aseptically processed.”
In Red Breast Syndrome, the patient’s breast turns a deep, fiery red. This is often misdiagnosed as an infection (cellulitis), leading to unnecessary rounds of heavy antibiotics. However, if the redness is caused by endotoxins on a product like FlexHD, the only solution is often to surgically remove the ADM. This “sterile inflammation” is a direct failure of the manufacturing process (21 CFR Part 820), and it is a central pillar of our South Dakota injury claims.
The GalaFLEX and Phasix Conflict
For those who received a bioabsorbable scaffold like GalaFLEX, the promise was that the mesh would disappear within 18 to 24 months. However, the FDA’s Manufacturer and User Facility Device Experience (MAUDE) database contains numerous reports of these materials causing “foreign body” reactions and remaining in the body much longer than advertised.
If you had a “mastopexy” or breast lift in Rapid City that used one of these “internal bra” scaffolds and you now feel hardness, see visible rippling, or experience “bottoming out” (where the implant falls below the fold), the scaffold may have failed to provide the support promised.
Federal Context: The Allergan BIOCELL Recalls and MDL 2921
If your South Dakota surgeon used Allergan BIOCELL textured implants in conjunction with a scaffold or ADM, you may be at specific risk for BIA-ALCL. The Multidistrict Litigation (MDL 2921) in the District of New Jersey, presided over by Judge Brian R. Martinotti, is currently handling thousands of these claims.
The bellwether trial for this litigation is currently scheduled for October 19, 2026. This date is significant because it will set the tone for settlements across the country. Our firm’s South Dakota clients benefit from our federal court admission (SDTX) and our ability to coordinate with national litigation strategies while providing the local, bilingual care that Lupe Peña and Ralph Manginello are known for.
Why Time is of the Essence for South Dakota Survivors
When a device fails, your body is effectively being re-traumatized. In South Dakota’s medical landscape, the concentration of power in a few hospital systems can make it feel difficult to question the care you received.
But you have rights. Under the Women’s Health and Cancer Rights Act of 1998, your insurance is required to cover the treatment of complications from a mastectomy-related reconstruction. This includes the removal of defective mesh.
By calling 1-888-ATTY-911, you are taking the first step toward holding the multi-billion-dollar manufacturers accountable for the “predicate creep” and off-label marketing that led to your injury. We have helped victims recover over $50 million in total compensation across various practice areas, including complex workplace and refined refinery accidents, and we bring that same fight to the South Dakota medical device arena.
Conclusion: We Are Your Advocates in South Dakota
No woman should have to wonder if the device meant to help her heal was actually a hidden danger. Whether you are in Sioux Falls, Rapid City, Brookings, or Watertown, we are ready to serve you.
Ralph Manginello’s twenty-seven years of continuous practice and our firm’s current leadership in high-profile institutional litigation mean that we don’t back down. Lupe Peña’s ability to conduct consultations in Spanish ensures that every member of our South Dakota community has a voice.
Contact the attorneys at Attorney911 today. Call 1-888-ATTY-911 (1-888-288-9911). We treat your story with the gravity and compassion it deserves. No win, no fee. Confidentiality is guaranteed.
Hablamos español. Lupe Peña realiza consultas en español de forma directa y sin intérpretes para las familias de South Dakota.
Procedural Posture of South Dakota Federal Courts
If a lawsuit is filed in federal court in South Dakota, it will be heard in the U.S. District Court for the District of South Dakota. This court has divisions in Sioux Falls (Southern Division), Rapid City (Western Division), Pierre (Central Division), and Aberdeen (Northern Division). Understanding the local rules of these divisions is essential for any successful product liability litigation. We have the experience needed to handle these complex jurisdictional questions.
Evidence to Preserve Now
If you are scheduled for a revision or explant surgery in South Dakota, it is critical to:
- Request that the explanted mesh or ADM be preserved. Do not let the hospital discard it as “medical waste.”
- Ensure pathology slides are created. BIA-ALCL and BIA-SCC require specific biopsies of the “capsule” tissue.
- Take photos of any visible redness or deformity.
- Save all medical bills and discharge papers.
At Attorney911, we help you manage this evidence from the very beginning. Your focus should be on your health; let us handle the manufacturer’s defense playbook. Call us at 1-888-ATTY-911.
